UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence

European neuropsychopharmacology, 2013-11, Vol.23 (11), p.1432-1442

2013

Volltextzugriff (PDF)

Belgian consensus on metabolic problems associated with atypical antipsychotics

International journal of psychiatry in clinical practice, 2005, Vol.9 (2), p.130-137

2005

Volltextzugriff (PDF)

Stratégies pharmacologiques dans la dépression résistante au traitement

French Journal of Psychiatry, 2018-11, Vol.1, p.S89

De Nayer, A.

2018

Volltextzugriff (PDF)

Effect of a collector bag for measurement of postpartum blood loss after vaginal delivery: cluster randomised trial in 13 European countries

BMJ, 2010-02, Vol.340 (7741), p.c293-c293

International edition, 2010

Volltextzugriff (PDF)

Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial

Journal of clinical psychopharmacology, 2008-06, Vol.28 (3), p.317-324

2008

Volltextzugriff (PDF)

An open study of sertraline in acute and continuation treatment of depressed out-patients

Journal of international medical research, 1997-11, Vol.25 (6), p.340-353

1997

Volltextzugriff (PDF)

Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring

International clinical psychopharmacology, 2006-03, Vol.21 Suppl 2, p.S11

2006

Volltextzugriff (PDF)

Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics

International journal of psychiatry in clinical practice, 2003, Vol.7 (1), p.59-66

2003

Volltextzugriff (PDF)

Controlled Comparison of Tianeptine, Alprazolam and Mianserin in the Treatment of Adjustment Disorders with Anxiety and Depression

Human psychopharmacology, 1996-07, Vol.11 (4), p.293-298

1996

Volltextzugriff (PDF)

Medicamental treatment of schizophrenia

Revue médicale de Bruxelles, 2010-09, Vol.31 (4), p.226-230

2010

Volltextzugriff (PDF)

Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients

Psychopharmacologia, 1989-06, Vol.98 (2), p.163-168

1989

Volltextzugriff (PDF)

Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone

Human psychopharmacology, 2005-12, Vol.20 (8), p.573-581

2005

Volltextzugriff (PDF)

Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety

The international journal of neuropsychopharmacology, 2002-06, Vol.5 (2), p.115-120

2002

Volltextzugriff (PDF)

Pregnancy, lactation and treatment with antipsychotic drugs

Schizophrenia research, 2003-03, Vol.60 (1), p.325-326

2003

Volltextzugriff (PDF)

Interest of a loading dose of milnacipran in endogenous depressive inpatients: Comparison with the standard regimen and with fluvoxamine

European neuropsychopharmacology, 1991, Vol.1 (2), p.113-121

1991

Volltextzugriff (PDF)

Traitement médicamenteux de la schizophrénie

Revue médicale de Bruxelles, 2010, Vol.31 (4), p.226-230

2010

Volltextzugriff (PDF)

Conference report: Belgian consensus on metabolic problems associated with atypical antipsychotics

Encéphale, 2007, Vol.33 (2), p.197

2007

Volltextzugriff (PDF)

Controlled comparison of milnacipran (F2207) 200 mg and amitriptyline in endogenous depressive inpatients

Human psychopharmacology, 1989-09, Vol.4 (3), p.221-227

1989

Volltextzugriff (PDF)

Paroxetine in Major Depression: a double blind comparison with fluvoxamine

Neuropsychopharmacology (New York, N.Y.), 2003-07, Vol.11 (4), p.264-264

2003

Volltextzugriff (PDF)

Symptom relief obtained with Venlafaxine versus fluoxetine in depressed patients with concomitant anxiety

European neuropsychopharmacology, 2000-09, Vol.10, p.242-242

2000

Volltextzugriff (PDF)

42 Maison de repos et maison de repos et de soins : une protection contre le suicide ?

NPG, 2008-09, Vol.8, p.A23-A24

2008

Volltextzugriff (PDF)

P01.42 Symptom relief obtained with venlafaxine versus fluoxetine in depressed patients with concomitant anxiety

European psychiatry, 2000-10, Vol.15 (S2), p.331-331s

2000

Volltextzugriff (PDF)

Six month compliance with fluoxetine or paroxetine treatment in depressed outpatients

European neuropsychopharmacology, 2002-10, Vol.12, p.208-208

2002

Volltextzugriff (PDF)

Gait analysis and motor point block in dynamic varus of the rear foot in a head injured adult

Archives of physical medicine and rehabilitation, 1996-08, Vol.77 (8), p.827-829

1996

Volltextzugriff (PDF)

A controlled comparison of sertraline and fluoxetine in acute and continuation treatment of major depression

Human psychopharmacology, 1995-09, Vol.10 (5), p.393-405

1995

Volltextzugriff (PDF)

1 – 25 von 322

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(227)
Mit Volltextzugriff
(213)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence

Belgian consensus on metabolic problems associated with atypical antipsychotics

Stratégies pharmacologiques dans la dépression résistante au traitement

Effect of a collector bag for measurement of postpartum blood loss after vaginal delivery: cluster randomised trial in 13 European countries

Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial

An open study of sertraline in acute and continuation treatment of depressed out-patients

Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring

Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics

Controlled Comparison of Tianeptine, Alprazolam and Mianserin in the Treatment of Adjustment Disorders with Anxiety and Depression

Medicamental treatment of schizophrenia

Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients

Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone

Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety

Pregnancy, lactation and treatment with antipsychotic drugs

Interest of a loading dose of milnacipran in endogenous depressive inpatients: Comparison with the standard regimen and with fluvoxamine

Traitement médicamenteux de la schizophrénie

Conference report: Belgian consensus on metabolic problems associated with atypical antipsychotics

Controlled comparison of milnacipran (F2207) 200 mg and amitriptyline in endogenous depressive inpatients

Paroxetine in Major Depression: a double blind comparison with fluvoxamine

Symptom relief obtained with Venlafaxine versus fluoxetine in depressed patients with concomitant anxiety

42 Maison de repos et maison de repos et de soins : une protection contre le suicide ?

P01.42 Symptom relief obtained with venlafaxine versus fluoxetine in depressed patients with concomitant anxiety

Six month compliance with fluoxetine or paroxetine treatment in depressed outpatients

Gait analysis and motor point block in dynamic varus of the rear foot in a head injured adult

A controlled comparison of sertraline and fluoxetine in acute and continuation treatment of major depression

Suchergebnisse filtern